Thrombocytopenia during intravenous valproic acid therapy in the neurological intensive care unit.

Thrombocytopenia is common in NCU patients. Because several clinical and laboratory factors are associated with thrombocytopenia, careful use of VPA should be considered in patients with these risk factors.